{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MDCX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDCX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","market":"US","secType":"STK","nameCN":"Medicus Pharma Ltd.","latestPrice":2.3758,"timestamp":1754421105797,"preClose":2.38,"halted":0,"volume":129041,"delay":0,"floatShares":6964800,"shares":15933444,"eps":0,"marketStatus":"Trading","change":-0.0042,"latestTime":"08-05 15:15:47 EDT","open":2.36,"high":2.5,"low":2.3054,"amount":307356.88653450005,"amplitude":0.081765,"askPrice":2.38,"askSize":150,"bidPrice":2.35,"bidSize":9956,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1754424000000},"marketStatusCode":2,"adr":0,"listingDate":1731560400000,"exchange":"NASDAQ","adjPreClose":2.38,"preHourTrading":{"tag":"盘前","latestPrice":2.4699,"preClose":2.38,"latestTime":"09:07 EDT","volume":1,"amount":2.4699,"timestamp":1754399267924},"postHourTrading":{"tag":"盘后","latestPrice":2.3606,"preClose":2.38,"latestTime":"19:29 EDT","volume":1090,"amount":2573.64,"timestamp":1754350142062},"volumeRatio":0.514609},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","floatShares":6964800,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.514609,"shares":15933444,"dividePrice":0,"high":2.5,"amplitude":0.081765,"preClose":2.38,"low":2.3054,"week52Low":1.8,"pbRate":"--","week52High":8.94,"institutionHeld":0,"latestPrice":2.3758,"committee":0.970315,"eps":0,"divideRate":0,"volume":129041,"delay":0,"ttmEps":0,"open":2.36,"prevYearClose":2.43,"prevWeekClose":2.57,"prevMonthClose":2.46,"prevQuarterClose":2.99,"fiveDayClose":2.59,"twentyDayClose":2.99,"sixtyDayClose":4.18},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MDCX\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDCX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2556389049","title":"BRIEF-Medicus Pharma Ltd - Co And Helixnano Enter MoU For Vaccine Development - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2556389049","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556389049?lang=en_us&edition=fundamental","pubTime":"2025-08-04 20:13","pubTimestamp":1754309602,"startTime":"0","endTime":"0","summary":"BRIEF-Medicus Pharma Ltd - Co And Helixnano Enter MoU For Vaccine Development - SEC FilingAug 4  - Medicus Pharma Ltd MDCX.O:MEDICUS PHARMA LTD - CO AND HELIXNANO ENTER MOU FOR VACCINE DEVELOPMENT - SEC FILINGMEDICUS PHARMA LTD - CO AND HELIXNANO TO COLLABORATE ON MRNA VACCINE-LOADED MNAS PRODUCTION THROUGH JV - SEC FILINGFurther company coverage: MDCX.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nFWN3TW0Q3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"gpt_icon":0},{"id":"2556389255","title":"Medicus Pharma and HelixNano Announce Vaccine Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2556389255","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556389255?lang=en_us&edition=fundamental","pubTime":"2025-08-04 19:59","pubTimestamp":1754308794,"startTime":"0","endTime":"0","summary":"An announcement from Medicus Pharma Ltd ( ($MDCX) ) is now available. On August 4, 2025, Medicus Pharma Ltd. and Helix Nanotechnologies Inc. announ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-and-helixnano-announce-vaccine-collaboration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-and-helixnano-announce-vaccine-collaboration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MDCX"],"gpt_icon":0},{"id":"2556386945","title":"Medicus Pharma Ltd - Co and Helixnano Enter Mou for Vaccine Development - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2556386945","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556386945?lang=en_us&edition=fundamental","pubTime":"2025-08-04 19:37","pubTimestamp":1754307458,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nFWN3TW0Q3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"gpt_icon":0},{"id":"2556981386","title":"Medicus Pharma Ltd. Announces New Clinical Study for Thermostable mRNA Vaccine Utilizing Innovative Microneedle Array Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2556981386","media":"Reuters","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556981386?lang=en_us&edition=fundamental","pubTime":"2025-08-04 19:31","pubTimestamp":1754307065,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd. Announces New Clinical Study for Thermostable mRNA Vaccine Utilizing Innovative Microneedle Array Technology. Medicus Pharma Ltd. has announced a new clinical study, in collaboration with Helix Nanotechnologies Inc., to explore the efficacy and safety of a thermostable mRNA-based vaccine using a proprietary Microneedle array  delivery platform. The study will compare the safety and preliminary efficacy of intramuscular injection versus intradermal MNA delivery of HelixNano's vaccine candidate, HN-0001, as part of a Phase 1 clinical bridging study. The study aims to assess the innovative combination of HelixNano's mRNA vaccine platform with Medicus' MNA technology. Results from this clinical study are anticipated to be presented in the future, contingent upon the successful formation of a joint venture between the two companies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accur","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDL34xW2N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":14,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1744862400000}}}